La vendita allo scoperto per Global Lights Acquisition Corp - Rights dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Global Lights Acquisition Corp - Rights. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Global Lights Acquisition Corp - Rights (NASDAQ:GLACR) Azioni, Report sulle vendite allo scoperto

Global Lights Acquisition Corp - Rights

No-fault laws are one of the contributing factors to why car insurance premiums climb higher in some states. Twelve states hold these rules and demand that your insurance covers your injuries after a crash despite who caused it.
What are no-fault laws? In a typical setup, the at-fault driver's insurance picks up the tab for your damages, but in no-fault states your own policy steps in to handle your injuries, regardless of blame. This hinges on Personal Injury Protection—PIP for short—a required coverage in these states. PIP takes care of costs tied to the accident including medical bills and lost wages. States like Florida, Michigan, and New York follow this system though each have their own set of rules regarding PIP and subsequent lawsuits.
Here's a twist: no-fault states often block lawsuits for pain and suffering unless injuries hit a serious mark—like severe harm or death. The goal? Fewer court battles and, ideally, lower premiums. But does this actually work out the way it is supposed to?
Supporters say no-fault laws smooth out the claims process because your insurer pays your PIP claim directly. This supposedly cuts delays and legal tangles. Fewer lawsuits over pain and suffering could trim administrative costs for insurance companies and if those savings stack up, they might show up as lower premiums, especially where lawsuit limits hold firm.
But there's a flip side. PIP coverage often costs more than optional medical payments in fault-based states. With its wide reach—covering medical expenses, lost income, and beyond—insurers face bigger payouts. Michigan once had unlimited medical benefits under PIP, sending premiums through the roof. Recent changes let drivers pick lower limits.
Fraud adds another layer to the insurance mess. In Florida and New York, staged crashes and padded claims have jacked up PIP expenses and insurers hit with these losses hike premiums to balance the books. Additionally every injured driver in a no-fault state files a claim with their own company, boosting claim numbers compared to fault-based systems. In at fault states, the number of claims files is half as it is usually only the at fault person filing.
As we&#8217;ve mentioned, insurance premiums depend heavily on where you live. High PIP limits, like Michigan's old standard, tend to mean pricier rates. Strict lawsuit caps can often hold costs down. Fraud also continues to be a huge issue and states that are able tackle fraud effectively can keep steady premiums.
Take Florida for example. Despite aims to curb litigation, fraud and lawsuits have pushed premiums far above the national average. Michigan's recent PIP adjustments hint that scaling back coverage can lighten the load. Other factors—accident frequency, medical costs, and city density—muddy the picture further.
If you live in a no-fault state it might be a good idea to check your PIP minimums to weigh if the extra coverage makes sense. Know your state's lawsuit threshold—it sets the bar for chasing damages beyond PIP. Adding uninsured or underinsured motorist coverage can shield you from drivers with skimpy policies, though PIP steps in either way.
Solid liability coverage matters in fault based states. If you cause a wreck, you'll cover the other side's damages. Optional medical payments coverage can act like PIP, but it often caps out lower.
In conclusion, are no-fault laws a true contributor to inflating premiums? It's a mixed bag. They can streamline claims and trim lawsuits and possibly cut costs. Mandatory PIP and fraud risks can nudge rates up. The real impact depends on your state's rules and broader trends. Understand your local setup and pick a policy that fits—your budget will feel the difference.

Legal

Personal Finance

Insurance

General

Do No-Fault Laws Drive Up Your Car Insurance Premiums?

News

Offerings

SYNX

Silynxcom Files For Stock Shelf Of Up To $50M

Cross Country Healthcare, Inc. ("Cross Country" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare.
As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ.

CCRN

Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction

Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) stock is down more than 13% since the end of January and has now <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44048486/bitcoins-24-correction-mostly-technical-say-experts">entered oversold territory.&nbsp;</a>
What To Know: Alphabet's relative strength index fell to 29.17 on Thursday, its lowest since September 2024. The stock's RSI rebounded slightly on Friday to 29.51 at the time of publication, but remains below the 30 level traditionally used to mark a stock as "oversold."&nbsp;
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/02/44051518/nvidia-tesla-lead-tech-stock-rebound-whats-driving-markets-friday">Nvidia, Tesla Lead Tech Stock Rebound: What&#8217;s Driving Markets Friday?</a>
The company faces multiple headwinds that may have sent investors running for the exit. Here's a look at some of Alphabet&#8217;s recent challenges:&nbsp;
Q4 Revenue Miss: Alphabet&#8217;s fourth-quarter earnings report released Feb.4 showed a slight miss in revenue, particularly in its cloud division. The shortfall, in a key growth area, raised concerns among investors and the stock dropped about 7% the next day. 
Regulatory Pressures: Alphabet faces several<a href="https://www.benzinga.com/news/legal/25/02/43930715/google-sued-over-ai-search-overviews-education-company-says-tech-giant-is-stealing-content-and-driving-publishers-out-of-business"> legal challenges</a>, including an ongoing antitrust case with the Department of Justice that is expected to be settled in mid-2025 and could result in the divestiture of key business segments, including Chrome and Android.
Additionally, China announced an antitrust probe into Alphabet in early February and the company is under investigation by the European Commission for potential violations of its Digital Markets Act.&nbsp;
AI Competition: Google faces potential threats to its search dominance from emerging AI technologies like OpenAI and DeepSeek. The company has<a href="https://www.benzinga.com/markets/equities/25/02/44031714/google-implements-layoffs-in-hr-and-cloud-divisions-as-ai-investment-accelerates-report"> initiated rounds</a> of layoffs in order to reallocate spending toward AI research and development.  
Alphabet also announced a significant increase in capital expenditure from $58 billion to $75 billion for the current year, much of which is AI-focused.&nbsp;
Time To Buy?&nbsp;
Some analysts view Alphabet's current oversold status as a buying opportunity given the stock has a strong balance sheet and is trading at a lower multiple compared to other Big Tech names.&nbsp;&nbsp;
The three most recent analyst ratings have an average price target of $226.67 between them, with an implied 31.74% upside for Alphabet shares. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/02/44007082/q4-gdp-holds-at-2-3-after-minor-revision-in-second-estimate">Q4 GDP Holds At 2.3% After Minor Revision In Second Estimate&nbsp;</a></li>
</ul>
Image: Shutterstock

Large Cap

Movers

Tech

GOOG

GOOGL

Alphabet Stock Enters Oversold Territory — Is It A Buying Opportunity?

Barclays analyst Brandt Montour maintains Marriott Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>) with a Overweight and lowers the price target from $116 to $97.

Price Target

Analyst Ratings

Barclays Maintains Overweight on Marriott Vacations, Lowers Price Target to $97

Middlesex Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSEX#NASDAQ">MSEX</a>) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.36 by 36.11 percent. This is a 53.12 percent increase over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $47.107 million which beat the analyst consensus estimate of $43.000 million by 9.55 percent. This is a 22.03 percent increase over sales of $38.602 million the same period last year.

Earnings

MSEX

Middlesex Water Q4 2024 GAAP EPS $0.49 Beats $0.36 Estimate, Sales $47.107M Beat $43.000M Estimate

MSGM

Motorsport Games Says On Feb 26, U.S. District Court For District Of Delaware Granted Summary Judgment Motion Filed By Co And Other Defendants; Court Rules In Favor Of Motorsport Games On All Counts

Barclays analyst Raimo Lenschow maintains Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) with a Equal-Weight and lowers the price target from $17 to $16.

JAMF

Barclays Maintains Equal-Weight on Jamf Holding, Lowers Price Target to $16

RVTY

Revvity Files For Mixed Shelf Offering; Size Not Disclosed

Contracts

Senior Senate Democrat Cantwell Says Elon Musk Comments On FAA's $2.4B Contract To Verizon Raise "Serious Red Flags"

HBAN

Huntington Bancshares Files For Mixed Shelf ; Size Not Disclosed

Management

Associated Capital Group's Douglas R. Jamieson To Retire As CEO, Effective March 17; Patrick Huvane To Become Interim CEO

Macro Economic Events

Economics

Federal Reserve

Fed's Goolsbee Says Will Have To See What Exactly Happens With Tariffs; Tariffs Can Take A Long Time To Impact Economy; Rise In Productivity Appears Real But Still Unsure How Long It Will Last

Financial Metrics for Six Months Ended December 31, 2024
<ul>
<li>Total revenue of $6.6 million, consisting of grant revenue</li>
<li>Available cash and equivalents of $6.9 million</li>
<li>Net loss of $5.7 million primarily attributable to the business engaging more engineers and project consultants to deliver studies and basic design of "VS1" (a 30 MW / 288 MWh reference CSP plant located in Port Augusta, South Australia)</li>
<li>Total diluted common shares outstanding as of December 31, 2024 of 29,973,504</li>
</ul>
Vast Renewables Limited ("Vast" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>), a renewable energy company specializing in concentrated solar thermal power ("CSP") energy systems that generate zero-carbon, utility-scale electricity and industrial process heat, today announced operational and financial results for the first half of the Company's fiscal 2025, comprising the six months ended December 31, 2024.

VSTE

Vast Renewables H1 2025 Revenue $6.6M, Consisting Of Grant Revenue

Fed's Goolsbee Says Inflation Data Is Still Higher Than We'd Like; Still Appear On A Path Back To 2% Inflation; Everything Keeps Us Up At Night; We Should Start Working Through Scenarios Of Trump Economic Agenda; Don't Have Enough Clarity To Forecast Off Trump Agenda Yet

Insider Trades

Goldman Sachs Form 4 Filing Shows CEO David M Solomon Reports Open Market Sale Of 2,415 Shares Of Co's Common Stock At Average Price Of $622.15/share On Feb 26

NTIP

Network-1 2024 Revenue $100,000, EPS $(0.13)

<a href="https://www.dsca.mil/press-media/major-arms-sales/israel-munitions-and-munitions-support" title="https://www.dsca.mil/press-media/major-arms-sales/israel-munitions-and-munitions-support">https://www.dsca.mil/press-media/major-arms-sales/israel-munitions-and-munitions-support</a>

Global

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

U.S. State Dept Approves Potential Sale Of Munitions And Munitions Support To Israel For An Estimated $2.04B

HOMB

Home Bancshares Inc Announces Tracy M. French To Retire As Chairman And Director On April 17, 2025

Leerink Partners analyst Mani Foroohar maintains Recursion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) with a Market Perform and lowers the price target from $7 to $6.

RXRX

Leerink Partners Maintains Market Perform on Recursion Pharmaceuticals, Lowers Price Target to $6

Comments

Global Lights Acquisition Corp - Rights

Vendite allo scoperto

Global Lights Acquisition Corp - Rights (NASDAQ:GLACR) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO